Skip to main content

Table 1 Comparison of the basic parameters of the study population by univariable logistic regression analysis

From: Development and validation of a prediction model for suboptimal ovarian response in polycystic ovary syndrome (PCOS) patients undergoing GnRH-antagonist protocol in IVF/ICSI cycles

 

SOR group

NOR group

P-value

N

165

148

 

Age

31.32 ± 4.66

30.01 ± 4.05

0.009

Weight

61.01 ± 9.90

60.67 ± 10.79

0.774

BMI

23.40 ± 3.42

23.41 ± 4.13

0.990

Primary fertility

  

0.699

Yes

85 (51.52%)

73 (49.32%)

 

No

80 (48.48%)

75 (50.68%)

 

Infertility years

3.58 ± 2.67

3.31 ± 2.35

0.351

Basal FSH

6.86 ± 1.72

5.73 ± 1.35

< 0.001

Basal LH

5.64 ± 3.53

5.85 ± 3.36

0.596

BasaLH/FSH

0.85 ± 0.54

1.04 ± 0.59

0.004

Basal prolactin

16.64 ± 7.74

16.84 ± 7.26

0.832

Basal estrogen

40.65 ± 17.32

39.33 ± 15.65

0.492

Basal testosterone

0.29 ± 0.19

0.34 ± 0.17

0.041

Basal progesterone

0.31 ± 0.20

0.32 ± 0.18

0.564

AMH

3.61 ± 2.38

5.39 ± 3.16

< 0.001

AFC

23.68 ± 3.59

23.61 ± 4.00

0.869

Glucose

4.88 ± 0.49

4.85 ± 0.53

0.589

Insulin

13.43 ± 7.26

11.94 ± 5.55

0.045

HOMA-IR

2.95 ± 1.76

2.61 ± 1.34

0.056

Initial Dosage of Gn

197.20 ± 58.93

168.50 ± 51.45

< 0.001

Total Gn dosage

1896.98 ± 636.64

1759.63 ± 758.59

0.083

Gn duration

8.71 ± 2.42

9.26 ± 2.39

0.046

  1. Values are presented as mean ± standard deviation or number (percentage)
  2. Abbreviations FSH, follicle-stimulating hormone ; LH, luteinizing hormone; AMH, anti-Mullerian hormone; AFC, total antral follicle count; BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance; Gn: gonadotropin;